BLRX
BioLineRx LtdNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$11.83M
P/E Ratio
0.00
EPS
$0.00
Beta
0.48
52W High
$7.77
52W Low
$2.15
50-Day MA
$2.53
200-Day MA
$3.28
Dividend Yield
—
Profit Margin
-99.60%
Forward P/E
93.46
PEG Ratio
0.20
About BioLineRx Ltd
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company is headquartered in Hevel Modi'in, Israel.
Fundamentals
| Revenue (TTM) | $1.18M |
| Gross Profit (TTM) | 950,000 |
| EBITDA | $-10.06M |
| Operating Margin | -1745.00% |
| Return on Equity | -11.00% |
| Return on Assets | -16.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.20 |
| Price-to-Book | 0.63 |
| Price-to-Sales (TTM) | 10.03 |
| EV/Revenue | 0.537 |
| EV/EBITDA | 0.01 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -98.30% |
| Shares Outstanding | $4.35M |
| Float | $2.50B |
| % Insiders | 4.00% |
| % Institutions | 1.10% |
Historical Volatility
HV 10-Day
117.77%
HV 20-Day
86.60%
HV 30-Day
86.76%
HV 60-Day
66.37%
HV Rank
86.5%
Volatility is currently expanding
Analyst Ratings
Consensus ($17.50 target)
2
BuyData last updated: 4/29/2026